# Mindfulness-based Psilocybin Therapy for PTSD

> **NCT07104916** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Anthony P King** · enrollment: 30 (estimated)

## Conditions studied

- Post Traumatic Stress Disorder
- Depression - Major Depressive Disorder

## Interventions

- **COMBINATION_PRODUCT:** Psilocybin + MBCT therapy
- **COMBINATION_PRODUCT:** Active Comparator: Psilocybin with Support Only

## Key facts

- **NCT ID:** NCT07104916
- **Lead sponsor:** Anthony P King
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2029-09
- **Final completion:** 2029-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07104916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07104916, "Mindfulness-based Psilocybin Therapy for PTSD". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT07104916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*